Hudson County 2023 COSSUP Site-based Program Application

The County of Hudson, New Jersey, is applying to the Comprehensive
Opioid, Stimulant, and Substance Use Site-based Program (COSSUP) under sub-category 1a.
This project will serve the County of Hudson, which has an urban population of 702,463
residents. The purpose of this project is to expand upon several current initiatives that help
prevent drug overdoses and reduce incidence of substance use across the county. The allowable
activities incorporated within our proposed project include law enforcement and first responder
deflection and diversion; real-time data collection; services for families impacted by their family
member’s substance use; and embedding behavioral health professionals, peers, and/or persons
with lived experience along the Sequential Intercept Model. Primary activities include:
continuation of the Overdose Fatality Review Team (OFRT) bi-monthly meetings and decedent
reviews for overdose fatalities; oversight of the OFRT sub-committee which develops
recommendations for preventing and reducing overdose; embedding a Community Navigator and
Peer Navigator within the Department of Health and Human Services who will receive clients
via referrals from parole/probation officers and the courts, including family court and recovery
court; launching a family support program which provides light case management and
referrals/linkages to services to affected family members of justice-involved individuals with
SUDs; community-wide naloxone kit distribution; crisis intervention trainings to the Hudson
County Regional SWAT Team and other officers; and launching a mobile unit outreach program
in collaboration with the Hudson County Sheriff’s Office. Overall, the proposed project will
support the implementation and expansion of several evidence-based, data-driven solutions at the
intersection of public health, public safety, and behavioral health. This project is critical to
ensuring best practices at all levels of care to improve outcomes of justice-involved individuals
with SUDs and reduce overdoses in the long-term.